FELTON, California, Oct. 8, 2019 /PRNewswire/ -- The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD
It's a known fact that amongst the elderly populace, there is a recurrence of acidic complications. This comes across as a challenge for gastroenterologist as well as the primary care provider. Plus, these patients do suffer from disorders like erosive esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein needs an amalgamation of therapies. This is where antacids come into picture.
Get Sample PDF and read more details about the "Antacids Market" Report 2025
Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the subsequent years. In other words, growing popularity on the part of e-Commerce coupled with increase in online medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by young children. "Gut" journal states that young children displayed obesity symptoms on intake of antacids. As far as infants are concerned, antacids are a strict "no-no". Even during pregnancy antacids should be avoided as chances of pre-mature birth can't be ruled out.
The antacids market is segmented on the basis of drug class, type of formulation, distribution channel, and geography. By drug class, the segmentation spans proton pump inhibitors, H2 antagonist (interventional/surgical simulators), and acid neutralizers. By type of formulation, the antacids industry comprises tablet, liquid, and powder. By distribution channel, it consists of retail pharmacies, hospital pharmacies, and the other distribution channels. By geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA.
The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy's Laboratories Ltd.
Browse 90 page research report with TOC on "Global Antacids Market" at: https://www.millioninsights.com/industry-reports/antacids-market
Browse reports of similar category available with Million Insights:
About Million Insights:
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
Ryan ManuelResearch Support Specialist, USAMillion InsightsPhone: 1-408-610-2300Toll Free: 1-866-831-4085Email: email@example.com
View original content:http://www.prnewswire.com/news-releases/antacids-market-is-likely-to-scale-new-heights-owing-to-poor-eating-habits-causing-acidity-and-ill-effects-of-anti-inflammatory-drugs-till-2025--million-insights-300933555.html
SOURCE Million Insights